Medical AI Future: Sustainable Reimbursement Strategies

By HEOR Staff Writer

May 6, 2024

Sustainable Reimbursement for Medical AI

Introduction

Artificial Intelligence (AI) in medicine has the potential to significantly enhance patient care, yet its widespread adoption is very dependent on sustainable reimbursement models. In a recent article, authors examine how fee-for-service (FFS) and value-based care (VBC) can facilitate the scaling of medical AI, and they propose strategies to align stakeholder interests.

The Challenge of Medical AI Reimbursement

Medical AI’s promise to enhance patient outcomes faces a significant obstacle: achieving sustainable reimbursement. Although the U.S. healthcare system offers a blueprint for this process, the path to reimbursement is filled with multiple complexities, necessitating the collaboration of diverse stakeholders.

Fee-for-Service: A Traditional Approach

FFS remains a prevalent model where medical AI services are billed similarly to other medical interventions. While this model offers transparency and can provide financial sustainability, it is not without risks, such as potential over utilisation and exacerbation of health disparities.

The Shift to Value-Based Care

VBC is reshaping the reimbursement landscape by focusing on patient outcomes and efficiency. This model accounts for a substantial portion of U.S. healthcare spending and offers fewer regulatory constraints. However, the real-world impact of VBC on cost and quality of care remains mixed.

Emerging Models and Real-World Cases

New reimbursement models are emerging, such as revenue-sharing approaches akin to the Medicare Part B drug payment system. Real-world cases, like autonomous AI for diabetic eye examinations, demonstrate how FFS and VBC can be effectively leveraged for reimbursement.

Accelerating Adoption Through Strategic Reimbursement

To expedite the adoption of medical AI, creators must navigate the reimbursement landscape effectively. This may involve pursuing FFS pathways, such as establishing a Current Procedural Terminology (CPT) code, or integrating into existing VBC frameworks like Merit-Based Incentive Payment Systems/ Healthcare Effectiveness Data and Information Set (MIPS/HEDIS).

Conclusion

The journey towards sustainable reimbursement for medical AI is complex, yet essential for its successful integration into healthcare. By understanding and utilising current FFS and VBC models, stakeholders can ensure that medical AI reaches its full potential in improving patient outcomes.

Reference url

Recent Posts

UC Biomed Building Investment
UC Biomed Building Investment: Advancing Research at the University of Coimbra

By João L. Carapinha

May 27, 2026

The Universidade de Coimbra (UC) is preparing to inaugurate its new UC Biomed building in the coming months, marking a significant milestone for the institution's biomedical research and teaching capabilities. According to recent updates, the facility—located at Polo III—has entered its final pha...
Health Innovation Award
Overview of the Health Innovation Award 2026: Promoting Sustainable Solutions in Healthcare
The Health Innovation Award continues its mission in 2026 by spotlighting data-driven projects that advance sustainability across Portugal’s health sector. Launched by Faculdade de Medicina da Universidade de Lisboa, Sanofi, and NTT DATA Portugal, it invites submissions through its dedicated plat...
health strategies Portugal
Commitment to Health Strategies in Portugal: A Pathway Towards Sustainable Change
In advancing health strategies in Portugal, the Ordem dos Farmacêuticos met with Adalberto Campos Fernandes to urge the country to move from promising ideas to concrete implementation of the